By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

T90.5 Sequelae of intracranial injury

AddAnalogsCompare
Medications used: More... hide
Pharm. gr. Substance Drugs
Tizanidine
Dihydroergotoxine
Ginkgo Bilobae leaf extract | | | | |
Nicergoline
Neostigmine methylsulfate
Ethylmethylhydroxypyridine succinate | | | | | | | | | | | | |
Levocarnitine
Sulpiride
Vinpocetine | |
Neostigmine bromide
Betahistine
Citicoline | | | | | | | | | | | | | |
Gamma-aminobutyric acid |
Glycine
Pyritinol
The substance is not described
Mesocarb

Tree of ICD-10 diagnoses

  1. Description
  2. Related diseases
  3. Related standards of medical care
  4. Basic medical services
  5. Clinics for treatment
T90.5 Sequelae of intracranial injury

Description

There is no detailed description, see related

Related diseases

T90.5 Sequelae of intracranial injury

Related standards of medical care

42a96bb5c8a2acfb07fc866444b97bf1
Available only when using PRO account
Content moderator: Vasin A. S.